DS
LGND icon

David Shaw’s Ligand Pharmaceuticals LGND Stock Holding History

David Shaw’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$885K Buy
2,800
+600
+27% +$141K ﹤0.01% 3825
2026
Q1 		$439K Buy
+2,200
New +$435K ﹤0.01% 3915
2020
Q3 		– Sell
-46,487
Closed -$3.24M – 4002
2020
Q2 		$3.24M Hold
46,487
– – ﹤0.01% 2014
2020
Q1 		$2.11M Buy
+46,487
New +$2.63M ﹤0.01% 2123
2019
Q4 		– Sell
-42,960
Closed -$2.67M – 4073
2019
Q3 		$2.67M Hold
42,960
– – ﹤0.01% 2143
2019
Q2 		$3.06M Buy
42,960
+8,015
+23% +$590K ﹤0.01% 1951
2019
Q1 		$2.74M Buy
34,945
+6,251
+22% +$474K ﹤0.01% 1947
2018
Q4 		$2.43M Buy
28,694
+962
+3% +$103K ﹤0.01% 1993
2018
Q3 		$4.75M Buy
27,732
+2,084
+8% +$314K 0.01% 1612
2018
Q2 		$3.31M Buy
25,648
+9,618
+60% +$1.07M ﹤0.01% 1831
2018
Q1 		$1.65M Buy
+16,030
New +$1.59M ﹤0.01% 2176
2017
Q3 		– Sell
-4,488
Closed -$340K – 3523
2017
Q2 		$340K Hold
4,488
– – ﹤0.01% 2981
2017
Q1 		$296K Buy
+4,488
New +$295K ﹤0.01% 2970
2014
Q3 		– Sell
-18,114
Closed -$704K – 4259
2014
Q2 		$704K Sell
18,114
-46,647
-72% -$1.89M ﹤0.01% 3242
2014
Q1 		$2.72M Buy
64,761
+23,243
+56% +$969K ﹤0.01% 2080
2013
Q4 		$1.36M Sell
41,518
-58,990
-59% -$1.92M ﹤0.01% 2891
2013
Q3 		$2.71M Buy
100,508
+75,982
+310% +$2.14M ﹤0.01% 2155
2013
Q2 		$573K Buy
+24,526
New +$441K ﹤0.01% 3142

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's LGND Position: Q2 2026 in Review

David Shaw reduced its Ligand Pharmaceuticals (LGND) stake by 28% in Q2 2026, selling an estimated $5.16M and leaving 56,515 shares worth $17.9M. The position accounts for 0.01% of the portfolio, ranked #1361.

David Shaw first reported a position in LGND in Q2 2013 and has held it in 37 quarters since. The position peaked at $22.9M in Q4 2018. 413 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • David Shaw held 56,515 shares of Ligand Pharmaceuticals worth $17.9M as of Q2 2026.
  • David Shaw sold 21,913 Ligand Pharmaceuticals shares in Q2 2026, an estimated $5.16M.
  • Ligand Pharmaceuticals made up 0.01% of David Shaw's portfolio in Q2 2026, its #1361 holding.
  • David Shaw first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 37 quarters since.
  • David Shaw's Ligand Pharmaceuticals position peaked at $22.9M in Q4 2018.
  • 413 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.